Prot #RXDX-101-02 / GO40782: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements

Project: Research project

Project Details

StatusActive
Effective start/end date7/11/16 → 12/31/25

Funding

  • Quintiles, Inc. (Prot #RXDX-101-02 // Prot #RXDX-101-02)
  • Ignyta, Inc. (Prot #RXDX-101-02 // Prot #RXDX-101-02)